← All indications
Molecular Mechanisms of Pharmacological Action
Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY.
Subtype terms (34)
More specific conditions that are subtypes of Molecular Mechanisms of Pharmacological Action in the MeSH hierarchy.
- Alkylating Agents
3 drugs (2 approved, 1 experimental)
- Amylin Receptor Agonists
- Angiotensin Receptor Antagonists
4 drugs approved
- Antacids
- Antidiuretic Hormone Receptor Antagonists
- Antifoaming Agents
- Antiglycation Agents
- Antimetabolites
13 drugs (8 approved, 5 experimental)
- Antioxidants
48 drugs (14 approved, 34 experimental)
- Aversive Agents
- Bradykinin Receptor Antagonists
- Calcitonin Gene-Related Peptide Receptor Antagonists
- CCR5 Receptor Antagonists
4 drugs (3 approved, 1 experimental)
- Cerumenolytic Agents
- Cystine Depleting Agents
- Cytochrome P-450 Enzyme Inducers
- Endothelin Receptor Antagonists
- Enzyme Activators
- Enzyme Inhibitors
12 drugs (10 approved, 2 experimental)
- Enzyme Reactivators
- Fibrin Modulating Agents
- Heparin Antagonists
- Immune Checkpoint Inhibitors
54 drugs (38 approved, 16 experimental)
- Membrane Transport Modulators
1 drug approved
- Mitosis Modulators
- Neurotransmitter Agents
7 drugs (6 approved, 1 experimental)
- Nitric Oxide Donors
- Peptidomimetics
- Radiopharmaceuticals
- Sequestering Agents
- Sodium-Glucose Transporter 2 Inhibitors
10 drugs (9 approved, 1 experimental)
- Sphingosine 1 Phosphate Receptor Modulators
- Toll-Like Receptor Agonists
- Viral Fusion Protein Inhibitors
Drugs by status
Phase 4 trials (6)
Phase 3 trials (3)
Phase 2 trials (7)
Phase 1 trials (7)